XML 46 R35.htm IDEA: XBRL DOCUMENT v3.7.0.1
Fair Value of Financial Instruments (Tables)
3 Months Ended
Mar. 31, 2017
Fair Value Disclosures [Abstract]  
Schedule of fair value assets and liabilities measured on recurring basis
The following table presents the balances of financial assets measured at fair value on a recurring basis at the dates indicated (dollars in thousands):
 
Fair Value Measurements at March 31, 2017 Using
 
Balance at March 31,
 
Quoted Prices in Active Markets for Identical Assets
 
Significant Other Observable Inputs
 
Significant Unobservable Inputs
Description
2017
 
Level 1
 
Level 2
 
Level 3
Assets:
 
 
 
 
 
 
 
Securities available for sale:
 
 
 
 
 
 
 
Federal agencies and GSEs
$
89,771

 
$

 
$
89,771

 
$

Mortgage-backed and CMOs
75,392

 

 
75,392

 

State and municipal
115,988

 

 
115,988

 

Corporate
9,373

 

 
9,373

 

Equity securities
2,043

 

 
2,043

 

Total
$
292,567

 
$

 
$
292,567

 
$

 
Fair Value Measurements at December 31, 2016 Using
 
Balance at December 31,
 
Quoted Prices in Active Markets for Identical Assets
 
Significant Other Observable Inputs
 
Significant Unobservable Inputs
Description
2016
 
Level 1
 
Level 2
 
Level 3
Assets:
 
 
 
 
 
 
 
Securities available for sale:
 
 
 
 
 
 
 
Federal agencies and GSEs
$
104,054

 
$

 
$
104,054

 
$

Mortgage-backed and CMOs
79,493

 

 
79,493

 

State and municipal
147,515

 

 
147,515

 

Corporate
13,492

 

 
13,492

 

Equity securities
1,948

 

 
1,498

 

Total
$
346,502

 
$

 
$
346,052

 
$

Schedule of assets that were measured at fair value on a nonrecurring basis
The following table summarizes the Company's assets that were measured at fair value on a nonrecurring basis at the dates indicated (dollars in thousands):
 
Fair Value Measurements at March 31, 2017 Using
 
Balance at March 31,
 
Quoted Prices in Active Markets for Identical Assets
 
Significant Other Observable Inputs
 
Significant Unobservable Inputs
Description
2017
 
Level 1
 
Level 2
 
Level 3
Assets:
 
 
 
 
 
 
 
Loans held for sale
$
1,872

 
$

 
$
1,872

 
$

Impaired loans, net of valuation allowance
1,905

 

 

 
1,905

Other real estate owned, net
1,664

 

 

 
1,664

 
Fair Value Measurements at December 31, 2016 Using
 
Balance at December 31,
 
Quoted Prices in Active Markets for Identical Assets
 
Significant Other Observable Inputs
 
Significant Unobservable Inputs
Description
2016
 
Level 1
 
Level 2
 
Level 3
Assets:
 
 
 
 
 
 
 
Loans held for sale
$
5,996

 
$

 
$
5,996

 
$

Impaired loans, net of valuation allowance
2,151

 

 

 
2,151

Other real estate owned, net
1,328

 

 

 
1,328

Schedule of quantitative information of assets measured at Level 3
The following tables summarize the Company's quantitative information about Level 3 fair value measurements at the dates indicated:
Quantitative Information About Level 3 Fair Value Measurements at March 31, 2017
Assets
 
Valuation Technique
 
Unobservable Input
 
Weighted
Rate
 
 
 
 
 
 
 
Impaired loans
 
Discounted appraised value
 
Selling cost
 
8
%
 
 
 
 
 
 
 
Other real estate owned, net
 
Discounted appraised value
 
Selling cost
 
8
%
Quantitative Information About Level 3 Fair Value Measurements at December 31, 2016
Assets
 
Valuation Technique
 
Unobservable Input
 
Weighted
Rate
 
 
 
 
 
 
 
Impaired loans
 
Discounted appraised value
 
Selling cost
 
8
%
 
 
 
 
 
 
 
Other real estate owned, net
 
Discounted appraised value
 
Selling cost
 
6
%
Schedule of carrying values and estimated fair values of the entity's financial instruments
The carrying values and estimated fair values of the Company's financial instruments at March 31, 2017 are as follows (dollars in thousands):
 
Fair Value Measurements at March 31, 2017 Using
 
 
 
Quoted Prices in Active Markets for Identical Assets
 
Significant Other Observable Inputs
 
Significant Unobservable Inputs
 
Fair Value
 
Carrying Value
 
Level 1
 
Level 2
 
Level 3
 
Balance
Financial Assets:
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
94,790

 
$
94,790

 
$

 
$

 
$
94,790

Securities available for sale
292,567

 

 
292,567

 

 
292,567

Restricted stock
5,492

 

 
5,492

 

 
5,492

Loans held for sale
1,872

 

 
1,872

 

 
1,872

Loans, net of allowance
1,206,850

 

 

 
1,204,240

 
1,204,240

Bank owned life insurance
18,270

 

 
18,270

 

 
18,270

Accrued interest receivable
4,482

 

 
4,482

 

 
4,482

 
 
 
 
 
 
 
 
 
 
Financial Liabilities:
 

 
 

 
 

 
 

 
 

Deposits
$
1,416,104

 
$

 
$
1,044,872

 
$
366,866

 
$
1,411,738

Repurchase agreements
47,776

 

 
47,776

 

 
47,776

Long-term borrowings
9,985

 

 

 
10,110

 
10,110

Junior subordinated debt
27,749

 

 

 
25,987

 
25,987

Accrued interest payable
574

 

 
574

 

 
574

The carrying values and estimated fair values of the Company's financial instruments at December 31, 2016 are as follows (dollars in thousands):
 
Fair Value Measurements at December 31, 2016 Using
 
 
 
Quoted Prices in Active Markets for Identical Assets
 
Significant Other Observable Inputs
 
Significant Unobservable Inputs
 
Fair Value
 
Carrying Value
 
Level 1
 
Level 2
 
Level 3
 
Balance
Financial Assets:
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
53,207

 
$
53,207

 
$

 
$

 
$
53,207

Securities available for sale
346,502

 

 
346,502

 

 
346,502

Restricted stock
6,224

 

 
6,224

 

 
6,224

Loans held for sale
5,996

 

 
5,996

 

 
5,996

Loans, net of allowance
1,152,020

 

 

 
1,136,961

 
1,136,961

Bank owned life insurance
18,163

 

 
18,163

 

 
18,163

Accrued interest receivable
5,083

 

 
5,083

 

 
5,083

 
 
 
 
 
 
 
 
 
 
Financial Liabilities:
 

 
 

 
 

 
 

 
 

Deposits
$
1,370,640

 
$

 
$
991,785

 
$
374,774

 
$
1,366,559

Repurchase agreements
39,166

 

 
39,166

 

 
39,166

Other short-term borrowings
20,000

 

 
20,000

 

 
20,000

Long-term borrowings
9,980

 

 

 
10,156

 
10,156

Junior subordinated debt
27,724

 

 

 
24,932

 
24,932

Accrued interest payable
623

 

 
623

 

 
623